by optimizenetz | Apr 27, 2015 | Medicine Cabinet
On April14, the Food & Drug Administration (FDA) panel reviewed the cardiovascular profile of saxagliptin (Onglyza by AstraZeneca), approved in 2009, and alogliptin (Nesina by Takeda), approved in 2013. Both medications are members of a class known as DPP-4...
by optimizenetz | Apr 17, 2015 | Medicine Cabinet
The FDA has recently approved Toujeo (insulin glargine injection), which is a long-acting insulin containing 300 Units/mL of insulin glargine. This insulin product comes in a 1.5ml pen that contains 450 units. Toujeo, a basal insulin, is approved for the improvement...
by optimizenetz | Apr 3, 2015 | All Things Tech
As a person with diabetes with a vested interest in technology, I know how cumbersome it can be to carry around multiple devices, including a cell phone, a tablet, a laptop computer, and in the case of a person with diabetes, an insulin pump along with supplies, extra...
